These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 32434192)
1. Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer. Ahopelto K; Laitinen A; Hagström J; Böckelman C; Haglund C Oncology; 2020; 98(9):643-652. PubMed ID: 32434192 [TBL] [Abstract][Full Text] [Related]
2. Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer. Ahopelto K; Böckelman C; Hagström J; Koskensalo S; Haglund C Cancer Biol Ther; 2016; 17(2):163-8. PubMed ID: 26650256 [TBL] [Abstract][Full Text] [Related]
3. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients. Song Y; Liu D; He G Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948 [TBL] [Abstract][Full Text] [Related]
4. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Krockenberger M; Engel JB; Schmidt M; Kohrenhagen N; Häusler SF; Dombrowski Y; Kapp M; Dietl J; Honig A Anticancer Res; 2010 May; 30(5):1653-9. PubMed ID: 20592357 [TBL] [Abstract][Full Text] [Related]
5. TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT. Ahopelto K; Saukkonen K; Hagström J; Kauhanen S; Seppänen H; Böckelman C; Haglund C Oncology; 2021; 99(3):177-185. PubMed ID: 33120381 [TBL] [Abstract][Full Text] [Related]
6. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer. Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961 [TBL] [Abstract][Full Text] [Related]
7. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Kayser G; Sienel W; Kubitz B; Mattern D; Stickeler E; Passlick B; Werner M; Zur Hausen A Pathology; 2011 Dec; 43(7):719-24. PubMed ID: 22027741 [TBL] [Abstract][Full Text] [Related]
8. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476 [TBL] [Abstract][Full Text] [Related]
9. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406 [TBL] [Abstract][Full Text] [Related]
10. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409 [TBL] [Abstract][Full Text] [Related]
11. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma. Shi Z; Tang Y; Li K; Fan Q Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094 [TBL] [Abstract][Full Text] [Related]
12. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Krockenberger M; Honig A; Rieger L; Coy JF; Sutterlin M; Kapp M; Horn E; Dietl J; Kammerer U Int J Gynecol Cancer; 2007; 17(1):101-6. PubMed ID: 17291239 [TBL] [Abstract][Full Text] [Related]
13. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749 [TBL] [Abstract][Full Text] [Related]
14. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513 [TBL] [Abstract][Full Text] [Related]
16. Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis. da Costa IA; Hennenlotter J; Stühler V; Kühs U; Scharpf M; Todenhöfer T; Stenzl A; Bedke J Urol Oncol; 2018 Oct; 36(10):472.e21-472.e27. PubMed ID: 30119993 [TBL] [Abstract][Full Text] [Related]
17. High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases. Peltonen R; Ahopelto K; Hagström J; Böckelman C; Haglund C; Isoniemi H Cancer Biol Ther; 2020 Sep; 21(9):826-831. PubMed ID: 32795237 [TBL] [Abstract][Full Text] [Related]
18. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166 [TBL] [Abstract][Full Text] [Related]
19. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis]. Wei B; Chen L; Li J Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538 [TBL] [Abstract][Full Text] [Related]
20. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Kayser G; Kassem A; Sienel W; Schulte-Uentrop L; Mattern D; Aumann K; Stickeler E; Werner M; Passlick B; zur Hausen A Diagn Pathol; 2010 Apr; 5():22. PubMed ID: 20385008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]